Normalizing Tumor Microenvironment Enables Novel Cancer Therapies - Episode Hero Image

Normalizing Tumor Microenvironment Enables Novel Cancer Therapies

Original Title: How A Fringe Idea Led To Lifesaving Cancer Treatments

TL;DR

  • Focusing on the tumor microenvironment, rather than just cancer cells, enables the development of seven FDA-approved treatments by revealing how abnormal blood vessels and matrix impair drug delivery and effectiveness.
  • Normalizing tumor blood vessels with anti-angiogenic drugs, initially developed to starve tumors, paradoxically improves drug delivery and enhances immunotherapy efficacy, leading to new treatment protocols.
  • Tumor pressure, exceeding arterial blood pressure, collapses blood vessels and is primarily caused by the extracellular matrix, necessitating normalization rather than complete removal.
  • Losartan, a cheap antihypertensive drug, normalizes tumor matrix and blood vessels, and crucially, reduces edema in glioblastoma, offering a potential new therapeutic avenue for this deadly cancer.
  • The significant reduction in NIH grant funding rates from 25% to 4% threatens scientific progress by hindering brilliant researchers and ideas, potentially ceding global leadership in medical innovation.
  • Pursuing counterintuitive research, like focusing on the tumor microenvironment, requires persistence through grant and paper rejections, but ultimately leads to profound advancements and patient benefits.

Deep Dive

Dr. Rakesh Jain's groundbreaking work reframes cancer treatment by shifting focus from the tumor itself to its surrounding environment, or "soil." This "seed and soil" hypothesis, long overlooked, argues that understanding and normalizing the tumor's microenvironment is critical for effective treatment, leading to the development of seven FDA-approved therapies.

Jain's research, initially met with skepticism and grant rejections, demonstrates that abnormal tumor blood vessels not only hinder drug delivery but also confer resistance to therapies. His engineering background allowed him to visualize these vessels, revealing that they are often poorly perfused and compressed by the tumor's matrix. This understanding led to the discovery that anti-angiogenic drugs, initially developed to starve tumors, can actually normalize blood vessels, improving drug penetration. More profoundly, this normalization enhances the effectiveness of immunotherapies, a synergistic effect now incorporated into treatments for lung, liver, endometrial, and kidney cancers.

Furthermore, Jain identified that the high pressure within tumors, caused by the extracellular matrix, collapses blood vessels. He found that losartan, a common and inexpensive blood pressure medication, can reduce this matrix pressure, thereby normalizing vessels. This normalization has shown promise not only for drug delivery but also for reducing edema in glioblastoma, a deadly brain tumor, although securing funding for clinical trials remains a significant challenge due to the drug's generic status. The broader implication for cancer research is the urgent need to address funding shortfalls, which threaten scientific progress and patient care by hindering brilliant minds and innovative ideas, particularly for junior researchers and the development of life-saving treatments.

Action Items

  • Audit tumor microenvironment: Assess matrix composition and pressure in 3-5 patient samples to identify normalization targets.
  • Evaluate losartan efficacy: Design a pilot study to test losartan's impact on glioblastoma edema and immune response.
  • Track blood vessel normalization: Measure blood flow and drug delivery efficiency across 5-10 tumor regions after anti-angiogenic treatment.
  • Analyze matrix-degrading enzymes: Investigate the role of specific enzymes in matrix pressure and identify potential therapeutic targets.

Key Quotes

"a tumor is more than a bag of cancer cells it's like an organ which has gone awry it's an organ which has its own rules and if we can figure out those rules we can improve not only detection but treatment of cancer and improve lives of patients"

Dr. Jain argues that a tumor should not be viewed simply as a collection of abnormal cells but as a complex organ with its own governing principles. He explains that understanding these underlying rules is key to advancing both the detection and treatment of cancer, ultimately benefiting patients.


"when i entered the field and even today most people focus on the cancer cells but i decided to focus is what you call the soil and uh i found out the soil it not only helps tumor grow that's understandable but also confers resistance to every form of therapy radiation therapy chemotherapy immunotherapy and all the future therapies which will be coming along"

Dr. Jain highlights his decision to shift research focus from the cancer cells themselves (the "seed") to their surrounding environment (the "soil"). He discovered that this tumor microenvironment not only supports tumor growth but also plays a critical role in conferring resistance to various cancer therapies.


"so i said to myself hold hold a second how can you deliver a drug if you cut off the blood supply what why would it make work better so in the meantime while i was doing experiments in mice i was seeing that when he give this drug you actually improve the blood supply so it does the exact opposite the opposite you got it"

Dr. Jain recounts his realization that anti-angiogenic drugs, intended to starve tumors by cutting off blood supply, paradoxically improved drug delivery in his experiments. He explains that these drugs actually enhanced blood supply, leading him to question the prevailing dogma and pursue a new therapeutic direction.


"normalizing vessels using anti drugs that were developed to kill them how did that go i was not they did not go well i will not dwell on it because i could give you a long history about my grant rejections paper rejections on and on but anyway what was the worst review just give one example well when somebody wrote to me what's dr jain smoking"

Dr. Jain describes the initial resistance and skepticism he faced when proposing the idea of using anti-angiogenic drugs to normalize tumor blood vessels, rather than destroy them. He shares an anecdote about a harsh review that questioned his sanity, illustrating the challenging reception his unconventional ideas received.


"human tumors apply pressures higher than 120 millimeters of mercury you know what i mean arterial blood pressures are about 100 so a tumor can compress apply pressure more than your heart can pump okay so it's a it's high pressure it's a high pressure zone it collapses which kind of explains why your your blood vessels are crimped you got it it collapses"

Dr. Jain explains that tumors generate significant internal pressure, exceeding normal arterial blood pressure, which leads to the collapse of blood vessels within the tumor. He details how this high-pressure environment impedes blood flow and drug delivery, presenting a critical challenge in cancer treatment.


"and you discover this cheap generic blood pressure medicine losartan that seems to reinflate the blood vessels is that sound right yeah it removes them yeah it it what does it do does it get rid of the matrix yeah what it does it reduces it same thing normalize it"

Dr. Jain confirms that the blood pressure medication losartan was found to reduce the matrix within tumors, thereby normalizing the tumor microenvironment and alleviating the pressure that collapses blood vessels. He emphasizes that this generic and inexpensive drug effectively "reinflates" the vessels by reducing the matrix, rather than removing it.

Resources

External Resources

Books

  • "The Seed and Soil Hypothesis" - Mentioned as a foundational concept in cancer research.

Research & Studies

  • Study on tumor microenvironment (National Cancer Institute) - Referenced as an early development in understanding tumor environments.
  • Study on drug delivery into tumors (Columbia University) - Discussed as foundational work on how medicines reach tumors.
  • Study on normalizing vessels using anti-angiogenic drugs (Nature Medicine, 2001) - Referenced as an early publication of Dr. Jain's controversial ideas.
  • Study on repairing vessels and immune therapy effectiveness (2012) - Cited as evidence that vessel repair improves immune therapy outcomes.
  • Study on Losartan decreasing edema in glioblastoma (2023) - Presented as recent findings supporting the use of Losartan for brain tumor swelling.

People

  • Dr. Rakesh Jain - Professor at Harvard Medical School and Massachusetts General Hospital, researcher on tumor microenvironments and drug delivery.
  • Professor Wayne - Dr. Jain's PhD advisor who introduced him to a tumor pathologist.
  • Dr. Judah Folkman - Distinguished colleague who proposed starving tumors by cutting off blood supply.
  • George El Jair - Researcher at the National Cancer Institute who developed early tumor visualization methods.

Organizations & Institutions

  • Bear Science - Mentioned as a supporter of rigorous scientific processes.
  • Harvard Medical School - Institution where Dr. Rakesh Jain studies tumor biology.
  • Massachusetts General Hospital - Institution where Dr. Rakesh Jain studies tumor biology.
  • National Cancer Institute (NCI) - Referenced for early tumor research and visualization studies.
  • Indian Institute of Technology, Kanpur - Institution where Dr. Jain received his undergraduate degree.
  • University of Delaware - Mentioned in relation to river pollution control modeling.
  • Columbia University - Institution where Dr. Jain was an assistant professor of chemical engineering.
  • National Institutes of Health (NIH) - Primary source of research funding discussed as facing funding challenges.

Websites & Online Resources

  • sciencefriday.com - Website for Science Friday.
  • alienware.com/deals - Website for Alienware deals.
  • dell.com/deals - Website for Dell deals.
  • dell.com - Website for Dell.

Other Resources

  • Seed and soil hypothesis - A concept in cancer research comparing tumors to seeds and their environment to soil.
  • Mass transfer - An engineering subject concerning the movement of substances from one place to another.
  • Anti-angiogenic drugs - Drugs developed to inhibit the growth of new blood vessels.
  • VEGF (Vascular Endothelial Growth Factor) - A factor that promotes blood vessel growth.
  • Bevacizumab (Avastin) - An anti-VEGF drug used in cancer treatment.
  • Chemotherapy - A cancer treatment method.
  • Immunotherapy - A cancer treatment method that uses the body's immune system.
  • Immune checkpoint blockers - A type of immunotherapy.
  • Matrix (collagen and hyaluronic acid) - Components of the tumor microenvironment that can block drug movement.
  • Microbiome - The community of microorganisms within a tumor.
  • Hypoxia - A condition of low oxygen levels.
  • Edema - Swelling caused by excess fluid accumulation.
  • Steroids - Medications used to control edema in brain tumors.
  • Losartan - An antihypertensive drug discussed for its potential to normalize tumor matrix and reduce edema.
  • Glioblastoma - A type of aggressive brain tumor.
  • Schwannomas - Benign tumors in the ear mentioned in relation to hearing recovery.

---
Handpicked links, AI-assisted summaries. Human judgment, machine efficiency.
This content is a personally curated review and synopsis derived from the original podcast episode.